糖尿病性黄斑水肿患者行玻璃体内皮质类固醇植入后眼压的监测和管理——2022年欧洲专家共识解读

2022-05-05 南昌大学第一附属医院眼科 眼科新进展

向玻璃体内植入皮质类固醇药物是治疗糖尿病性黄斑水肿的有效方法,但存在引起患者高眼压的副作用。为规范皮质类固醇植入物的临床使用,一些来自欧洲各地的眼科专家近期发布了关于“糖尿病性黄斑水肿患者

中文标题:

糖尿病性黄斑水肿患者行玻璃体内皮质类固醇植入后眼压的监测和管理——2022年欧洲专家共识解读

发布日期:

2022-05-05

简要介绍:

向玻璃体内植入皮质类固醇药物是治疗糖尿病性黄斑水肿的有效方法,但存在引起患者高眼压的副作用。为规范皮质类固醇植入物的临床使用,一些来自欧洲各地的眼科专家近期发布了关于“糖尿病性黄斑水肿患者行玻璃体内皮质类固醇植入后眼压的监测和管理”的共识,本文对该共识进行全面解读。 

相关资料下载:
[AttachmentFileName(sort=1, fileName=糖尿病性黄斑水肿患者行玻璃体内皮质类固醇植入后眼压的监测和管理——2022年欧洲专家共识解读.pdf)] GetToolGuiderByIdResponse(projectId=1, id=3b3a51c002a60973, title=糖尿病性黄斑水肿患者行玻璃体内皮质类固醇植入后眼压的监测和管理——2022年欧洲专家共识解读, enTitle=, guiderFrom=眼科新进展, authorId=0, author=, summary=向玻璃体内植入皮质类固醇药物是治疗糖尿病性黄斑水肿的有效方法,但存在引起患者高眼压的副作用。为规范皮质类固醇植入物的临床使用,一些来自欧洲各地的眼科专家近期发布了关于“糖尿病性黄斑水肿患者, cover=https://img.medsci.cn/20220606/1654493907105_1608702.jpg, journalId=0, articlesId=null, associationId=2799, associationName=南昌大学第一附属医院眼科, associationIntro=南昌大学第一附属医院眼科, copyright=0, guiderPublishedTime=Thu May 05 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #666666;">向玻璃体内植入皮质类固醇药物是治疗糖尿病性黄斑水肿的有效方法,但存在引起患者高眼压的副作用。为规范皮质类固醇植入物的临床使用,一些来自欧洲各地的眼科专家近期发布了关于&ldquo;糖尿病性黄斑水肿患者行玻璃体内皮质类固醇植入后眼压的监测和管理&rdquo;的共识,本文对该共识进行全面解读。&nbsp;</span></p>, tagList=[TagDto(tagId=32673, tagName=糖尿病性黄斑水肿), TagDto(tagId=34566, tagName=眼压), TagDto(tagId=438900, tagName=皮质类固醇植入物), TagDto(tagId=438901, tagName=玻璃体内植入)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌, tenant=100), CategoryDto(categoryId=32, categoryName=眼科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=24972, appHits=99, showAppHits=0, pcHits=207, showPcHits=24873, likes=1, shares=19, comments=7, approvalStatus=1, publishedTime=Mon Jun 06 15:35:00 CST 2022, publishedTimeString=2022-05-05, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=dajiong, createdTime=Mon Jun 06 13:38:00 CST 2022, updatedBy=6459136, updatedName=艺玮, updatedTime=Tue Jan 02 11:34:19 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=糖尿病性黄斑水肿患者行玻璃体内皮质类固醇植入后眼压的监测和管理——2022年欧洲专家共识解读.pdf)])
糖尿病性黄斑水肿患者行玻璃体内皮质类固醇植入后眼压的监测和管理——2022年欧洲专家共识解读.pdf
下载请点击:
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1234401, encodeId=6647123440193, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732b5599560, createdName=ms7000000004042513, createdTime=Sun Jul 24 14:51:45 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232555, encodeId=23061232555cc, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08605478769, createdName=ms2000002069621106, createdTime=Fri Jul 15 00:37:27 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226532, encodeId=e1291226532a6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df621297957, createdName=245462683, createdTime=Wed Jun 15 07:57:52 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225083, encodeId=d0c91225083ba, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44565409552, createdName=眼科芳, createdTime=Tue Jun 07 22:22:05 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225032, encodeId=28fd1225032b1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/03/50376e36a7cc3ba0e25d5bd2ceec50a0.jpg, createdBy=e28a5193434, createdName=我们的祖国像花园, createdTime=Tue Jun 07 18:18:27 CST 2022, time=2022-06-07, status=1, ipAttribution=)]
    2022-07-24 ms7000000004042513

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1234401, encodeId=6647123440193, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732b5599560, createdName=ms7000000004042513, createdTime=Sun Jul 24 14:51:45 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232555, encodeId=23061232555cc, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08605478769, createdName=ms2000002069621106, createdTime=Fri Jul 15 00:37:27 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226532, encodeId=e1291226532a6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df621297957, createdName=245462683, createdTime=Wed Jun 15 07:57:52 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225083, encodeId=d0c91225083ba, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44565409552, createdName=眼科芳, createdTime=Tue Jun 07 22:22:05 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225032, encodeId=28fd1225032b1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/03/50376e36a7cc3ba0e25d5bd2ceec50a0.jpg, createdBy=e28a5193434, createdName=我们的祖国像花园, createdTime=Tue Jun 07 18:18:27 CST 2022, time=2022-06-07, status=1, ipAttribution=)]
    2022-07-15 ms2000002069621106

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1234401, encodeId=6647123440193, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732b5599560, createdName=ms7000000004042513, createdTime=Sun Jul 24 14:51:45 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232555, encodeId=23061232555cc, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08605478769, createdName=ms2000002069621106, createdTime=Fri Jul 15 00:37:27 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226532, encodeId=e1291226532a6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df621297957, createdName=245462683, createdTime=Wed Jun 15 07:57:52 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225083, encodeId=d0c91225083ba, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44565409552, createdName=眼科芳, createdTime=Tue Jun 07 22:22:05 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225032, encodeId=28fd1225032b1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/03/50376e36a7cc3ba0e25d5bd2ceec50a0.jpg, createdBy=e28a5193434, createdName=我们的祖国像花园, createdTime=Tue Jun 07 18:18:27 CST 2022, time=2022-06-07, status=1, ipAttribution=)]
    2022-06-15 245462683

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1234401, encodeId=6647123440193, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732b5599560, createdName=ms7000000004042513, createdTime=Sun Jul 24 14:51:45 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232555, encodeId=23061232555cc, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08605478769, createdName=ms2000002069621106, createdTime=Fri Jul 15 00:37:27 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226532, encodeId=e1291226532a6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df621297957, createdName=245462683, createdTime=Wed Jun 15 07:57:52 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225083, encodeId=d0c91225083ba, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44565409552, createdName=眼科芳, createdTime=Tue Jun 07 22:22:05 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225032, encodeId=28fd1225032b1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/03/50376e36a7cc3ba0e25d5bd2ceec50a0.jpg, createdBy=e28a5193434, createdName=我们的祖国像花园, createdTime=Tue Jun 07 18:18:27 CST 2022, time=2022-06-07, status=1, ipAttribution=)]
    2022-06-07 眼科芳

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1234401, encodeId=6647123440193, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=732b5599560, createdName=ms7000000004042513, createdTime=Sun Jul 24 14:51:45 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232555, encodeId=23061232555cc, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08605478769, createdName=ms2000002069621106, createdTime=Fri Jul 15 00:37:27 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226532, encodeId=e1291226532a6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df621297957, createdName=245462683, createdTime=Wed Jun 15 07:57:52 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225083, encodeId=d0c91225083ba, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44565409552, createdName=眼科芳, createdTime=Tue Jun 07 22:22:05 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225032, encodeId=28fd1225032b1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/03/50376e36a7cc3ba0e25d5bd2ceec50a0.jpg, createdBy=e28a5193434, createdName=我们的祖国像花园, createdTime=Tue Jun 07 18:18:27 CST 2022, time=2022-06-07, status=1, ipAttribution=)]
    2022-06-07 我们的祖国像花园

    学习了

    0